Confident Investing Starts Here:
- Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter
An announcement from Senzime AB ( (SE:SEZI) ) is now available.
Senzime AB has announced an extraordinary general meeting to be held on June 30, 2025, to approve a directed share issue. This strategic move aims to inject new capital into the company by issuing a maximum of 700,000 new shares, specifically directed to Adam Dahlberg, to strengthen its financial position and support its growth initiatives.
More about Senzime AB
Senzime AB operates in the medical technology industry, focusing on developing and marketing systems for patient monitoring. The company is known for its innovative solutions that enhance patient safety and optimize healthcare efficiency.
YTD Price Performance: -15.45%
Average Trading Volume: 182,324
Current Market Cap: SEK619.3M
For an in-depth examination of SEZI stock, go to TipRanks’ Stock Analysis page.
Trending Articles:
Looking for a trading platform? Check out TipRanks' Best Online Brokers guide, and find the ideal broker for your trades.
Report an Issue